Error in Supplement 2 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to Supplement 2: Misspelling of a Collaborator’s Name

  • October 19, 2026

Share

  • 1

    A correction addressed a misspelling in Supplement 2.

  • 2

    The misspelled name belonged to nonauthor collaborator Ahmet Bulent Dogrul.

  • 3

    The correction concerns the Original Investigation titled “Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms.”.

  • 4

    The Original Investigation was published March 27, 2026.

  • 5

    The correction was limited to the collaborator’s name in Supplement 2.

Original Source(s)

Error in Supplement 2

  • October 19, 2026

Related Content

Cancer Treatment During Pregnancy and Maternal and Infant Outcomes: A Descriptive Cohort Study Using a Japanese Claims Database

CRISPR-Based Delivery System Generates CAR T Cells In Vivo

A two-vector delivery system generates tumor-targeting CAR T cells directly inside the body, achieving complete responses in mouse cancer models

  • October 13, 2026

  • 3 min
2026 ASCO Breast Cancer Highlights: HER2CLIMB-05

Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the HER2Climb-05 trial and how it impacts treatment for HER2+ metastatic breast cancer

  • October 15, 2026

  • 1 min